Skip to main content
Livermore
Livermore
ZHEN

RVL Pharmaceuticals plc

RVLPDelisted Nov 20, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001739426

RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.

13F holders, Q1 2024

Institutional positions in RVL Pharmaceuticals plc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

RVLP is no longer listed, and 13F filings after Q3 2023 list far fewer holders. See Q3 2023

Institutional holders
0
−3 vs. Q4 2023
Shares held
0
−211.2K (−100.0%) vs. Q4 2023
Total value
$0
−$613 (−100.0%) vs. Q4 2023
New holders
0
0 more added
Sold out
3
0 more reduced

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RVLP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 0 institutions
Q1 2021: 55 institutionsQ2 2021: 46 institutionsQ3 2021: 35 institutionsQ4 2021: 31 institutionsQ1 2022: 36 institutionsQ2 2022: 38 institutionsQ3 2022: 46 institutionsQ4 2022: 36 institutionsQ1 2023: 41 institutionsQ2 2023: 36 institutionsQ3 2023: 32 institutionsQ4 2023: 3 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2024: $0
Q1 2021: $25.7MQ2 2021: $14.5MQ3 2021: $11.9MQ4 2021: $18.7MQ1 2022: $27.8MQ2 2022: $22.2MQ3 2022: $50.5MQ4 2022: $28.0MQ1 2023: $28.7MQ2 2023: $13.5MQ3 2023: $1.57MQ4 2023: $613Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding RVLP and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20233$613
Q3 202332$1.57M
Q2 202336$13.5M
Q1 202341$28.7M
Q4 202236$28.0M
Q3 202246$50.5M
Q2 202238$22.2M
Q1 202236$27.8M
Q4 202131$18.7M
Q3 202135$11.9M
Q2 202146$14.5M
Q1 202155$25.7M

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding RVL Pharmaceuticals plc; share changes are against Q4 2023.

Institutions holding RVLP in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
XTX Topco Ltd0$00.00%−180,566−100.0%Sold out
Raymond James & Associates0$00.00%−23,696−100.0%Sold out
Simplex Trading, LLC0$00.00%−6,900−100.0%Sold out